Home » Topics » BioWorld Science

BioWorld Science
RSS

KalVista Pharmaceuticals patents FXIIa inhibitors

June 29, 2022

Vilnius University presents new carbonic anhydrase IX ligands

June 29, 2022

Eternity Bioscience synthesizes IRAK4 inhibitors

June 29, 2022

Wellstat Therapeutics divulges novel uridine derivatives

June 29, 2022

Orion Corporation patents new CYP11A1 inhibitors

June 29, 2022

Design of a novel TAM inhibitor as a potential cancer therapy

June 29, 2022

Researchers identify DAW1 gene variants linked to motile ciliopathy

June 29, 2022

CYSLTR1 blockade as a strategy to prevent breast cancer progression

June 29, 2022

Confo awarded grant to support GPCR drug discovery

June 28, 2022

Ideaya selects Pol Theta Helicase development candidate

June 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.